Fibromyalgia Trials in Cincinnati, United States
Conditions / Fibromyalgia / Cincinnati, United States
Fibromyalgia has been the subject of sustained clinical investigation across multiple research sites.
52 total trials for this combination
Showing top 10 of 52 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00301431 | Study Evaluating the Efficacy of DVS-233 in Fibromyalgia | TERMINATED | PHASE2/PHASE3 |
| NCT00612170 | A 14-week, Multi-center Study of [S,S]-Reboxetine in Patients With Fibromyalgia. | COMPLETED | PHASE3 |
| NCT00645398 | A Study of the Efficacy and Safety of Pregabalin for the Treatment of Fibromyalgia | COMPLETED | PHASE3 |
| NCT00071162 | Genetics of Fibromyalgia | UNKNOWN | — |
| NCT00423605 | Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. | COMPLETED | PHASE3 |
| NCT00151528 | An Open-Label Trial of Pregabalin in Patients With Fibromyalgia | COMPLETED | PHASE3 |
| NCT00424892 | Study Evaluating DVS SR in Patients With Fibromyalgia Syndrome | COMPLETED | PHASE2/PHASE3 |
| NCT00423813 | A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia. | COMPLETED | PHASE3 |
| NCT00151489 | Safety and Efficacy Study of Pregabalin in Fibromyalgia | COMPLETED | PHASE3 |
| NCT00754221 | Open Label Extension Study of [S,S]-Reboxetine in Patients With Fibromyalgia | TERMINATED | PHASE3 |